Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Journal of Autoimmune Diseases

Figure 2

From: Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis

Figure 2

Immunoblot pattern produced by a serum sample from a liver kidney microsomal type 1 (LKM1) negative chronic hepatitis C virus (HCV) infected patient with anti-formimino-transferase cyclodeaminase (FTCD) antibodies on electrophoretically separated human liver homogenate (lane 1). The 58–60 kDa immunofixed band almost completely abolished when the reactive serum was pre-incubated with recombinant FTCD as solid phase competitor (lane 2).

Back to article page